Proteinuria
AKI Evidence
Its all about Ion's
Medicines and their mechanisms
Under the microscope
100
According to the KDIGO 2025 guideline, this is the proteinuria threshold (in grams per day) at which patients are considered at risk of progressive kidney function loss and should be considered for treatment. The ideal treatment goal is to reduce proteinuria even further — below 0.3 g/d — while maintaining an eGFR decline rate of less than 1 mL/min/year
What is 0.5 g/day (≥0.5 g/d)?
100
In the KDIGO staging system, this stage is defined by a serum creatinine rise to ≥3.0 times baseline, OR an increase to ≥4.0 mg/dL, OR initiation of renal replacement therapy, OR (in patients <18 years) a decrease in eGFR to <35 mL/min/1.73 m². The urine output criterion is <0.3 mL/kg/h for ≥24 hours or anuria for ≥12 hours.
What is Stage 3 AKI?
100
A patient on long-term omeprazole presents with refractory hypokalemia that fails to correct despite aggressive potassium replacement. The underlying cause is this electrolyte deficiency, which occurs in approximately 20% of chronic PPI users through a dose-dependent mechanism involving reduced intestinal absorption this electrolyte due to altered luminal pH and gut microbiome changes. Electrolyte abnormality responsible for this condition is
What is Hypomagnesemia?
100
This class of oral antidiabetic agents blocks a transporter in the proximal tubule, increasing sodium delivery to the macula densa and restoring tubuloglomerular feedback. The resulting afferent arteriolar constriction reduces intraglomerular pressure and hyperfiltration — explaining the characteristic initial "dip" in eGFR that is actually a sign of renoprotection
What are SGLT2 inhibitors?
100
These coffin-lid–shaped crystals precipitate in alkaline urine (pH > 7.0) and are composed of magnesium ammonium phosphate. Their presence on urine microscopy should raise concern for infection with urease-producing organisms such as Proteus mirabilis, which can lead to this type of branching renal stone.
What are struvite (staghorn) calculi?
200
According to the "4-hit hypothesis" of IgA nephropathy pathogenesis, the process begins with aberrant production of this specific immunoglobulin at the gut or respiratory mucosa. This molecule enters the systemic circulation, is recognized by circulating IgG and IgA autoantibodies forming immune complexes, and ultimately deposits in the glomerular mesangium to trigger inflammation and complement activation.
What is galactose-deficient IgA1 (Gd-IgA1)?
200
The KDIGO guideline recommends that all patients on CRRT without increased bleeding risk receive anticoagulation (1B). For CRRT specifically, the guideline suggests this form of anticoagulation over heparin (2B), even extending this recommendation to patients with increased bleeding risk who do not have contraindications (2C). This strategy was associated with significantly longer filter life span (median 46.1 vs. 26.7 hours, p < 0.001) compared to systemic heparin, with no difference in 90-day mortality.
What is regional citrate anticoagulation?
200
In CKD, this bone-derived hormone is the earliest detectable biomarker of disordered mineral metabolism — rising before serum phosphate or PTH become abnormal. It is produced by osteocytes in response to phosphate retention, provides a compensatory increase in renal phosphate excretion, and simultaneously inhibits renal 1-alpha-hydroxylase, thereby reducing 1,25-dihydroxyvitamin D production.
What is FGF 23?
200
This locally acting NHE3 inhibitor works in the gut — not the kidney — to reduce serum phosphorus in dialysis patients. By inhibiting the sodium/hydrogen exchanger 3 on the apical surface of intestinal epithelium, it decreases paracellular phosphate permeability, offering a mechanistically distinct alternative to traditional phosphate binders
What is XPHOZAH (tenapanor)?
200
These hexagonal, flat crystals seen in acidic urine are pathognomonic for an autosomal recessive disorder of amino acid transport and indicate a high risk of recurrent nephrolithiasis beginning in childhood.
What are cystine crystals?
300
The Columbia Classification (2004) identifies five mutually exclusive histologic variants of FSGS based on light microscopy. Among them, this variant — characterized by wrinkling of the glomerular capillary wall with overlying podocyte hyperplasia and hypertrophy — carries the worst prognosis, with a 65% rate of ESRD and only a 13% remission rate. It is strongly associated with HIV-associated nephropathy and APOL1 high-risk genotypes.
What is the collapsing variant?
300
In the furosemide stress test, this is the IV bolus dose administered to patients who have received loop diuretics within the prior 7 days. A urine output of less than 200 mL over 2 hours after this dose predicts progression to severe AKI with a sensitivity of 87.1% and specificity of 84.1%.
What is 1.5 mg/kg of intravenous furosemide?
300
This landmark equation, first described in 1958, demonstrates that serum sodium concentration is determined by the ratio of total body exchangeable sodium plus exchangeable potassium to total body water: [Na⁺]s ≈ (Naₑ + Kₑ) / TBW. It reveals that hyponatremia fundamentally represents excess water relative to exchangeable cations — and critically, that potassium depletion can cause or worsen hyponatremia even without sodium loss.
What is the Edelman equation?
300
This injectable GLP-1 receptor agonist, given once weekly at 1.0 mg, was the first in its class to demonstrate a primary kidney outcome benefit in a dedicated renal trial (FLOW Trial). In the FLOW trial, it reduced the composite primary endpoint — persistent ≥50% eGFR decline, eGFR <15 mL/min/1.73 m², dialysis or transplant, or death from kidney or cardiovascular causes — by 24% (HR 0.76, 95% CI 0.66–0.88) in patients with type 2 diabetes and CKD.
What is semaglutide (Ozempic)?v
300
This is the minimum number of glomeruli generally recommended in a kidney biopsy sample to diagnose or exclude a specific histopathologic pattern with reasonable confidence, according to KDIGO guidelines.
What is 8-10 glomeruli?
400
In this landmark 2019 NEJM trial (n=130), rituximab was compared to cyclosporine in patients with primary membranous nephropathy and proteinuria ≥5 g/day. At 12 months, remission rates were similar (60% vs. 52%), meeting the noninferiority endpoint. However, at 24 months, rituximab demonstrated clear superiority — 60% vs. 20% maintained remission — driven by a dramatically lower relapse rate after treatment cessation. This trial established rituximab as a preferred first-line immunosuppressive agent over calcineurin inhibitors.
What is the MENTOR trial (Membranous Nephropathy Trial of Rituximab)?
400
The KDIGO guideline provides its strongest level of recommendation (Grade 1A) against using this agent — once commonly given at 1–3 µg/kg/min for "renal protection" in the ICU — to prevent or treat AKI. Multiple negative studies, including an adequately powered RCT, demonstrated no benefit, and the drug can actually increase renal vascular resistance in AKI patients while also triggering tachyarrhythmias, myocardial ischemia, and T-cell suppression.
What is low-dose dopamine?
400
After years of secondary hyperparathyroidism in CKD, prolonged stimulation by hypocalcemia, hyperphosphatemia, and low calcitriol drives monoclonal expansion of parathyroid cells with downregulation of both the calcium-sensing receptor (CaSR) and vitamin D receptor (VDR). The glands develop nodular hyperplasia — and begin secreting PTH autonomously, no longer suppressible by rising calcium levels. This results in the biochemical triad of hypercalcemia, hyperphosphatemia, and markedly elevated PTH. It is most commonly recognized after renal transplantation (persistent hypercalcemia in 8.5–65% of post-transplant patients) but also occurs in long-standing dialysis patients. Parathyroidectomy is recommended when PTH exceeds 800 pg/mL and medical therapy with calcimimetics fails.
What is tertiary hyperparathyroidism?
400
This humanized IgG2 monoclonal antibody selectively binds to and neutralizes APRIL (A Proliferation-Inducing Ligand), a cytokine that mediates antibody class switching in mature B cells and plasma cell survival. By suppressing APRIL, it reduces production of the pathogenic galactose-deficient IgA1 molecules that trigger autoantibody formation and immune complex deposition in the glomerular mesangium — directly targeting the "multi-hit" immunopathogenesis of IgA nephropathy.
What is sibeprenlimab (Voyxact)?
400
On immunofluorescence microscopy, this glomerulonephritis is characterized by intense, diffuse, linear staining for IgG along the glomerular basement membrane — in contrast to the granular pattern seen in immune-complex–mediated disease
What is anti-GBM disease?
500
In the phase 3 REGENCY trial (NEJM, 2025), 271 adults with biopsy-proven active lupus nephritis were randomized 1:1 to receive this drug (1000 mg on day 1 and at weeks 2, 24, 26, and 52) or placebo, all on background mycophenolate mofetil and prednisone. The primary endpoint — complete renal response at week 76 (UPCR <0.5, eGFR ≥85% of baseline, no intercurrent event) — was achieved in 46.4% vs. 33.1% (adjusted difference 13.4 percentage points; P=0.02).
What is obinutuzumab?
500
In the PROTECTION trial — the largest RCT to demonstrate pharmacologic prevention of cardiac surgery-associated AKI — 3,511 patients received a continuous intravenous infusion of a balanced amino acid mixture at this specific dose (expressed per ideal body weight per day), started in the operating room and continued for up to 72 hours. The intervention reduced overall AKI by 15% (RR 0.85) and Stage 3 AKI by 44% (RR 0.56) compared to placebo.
What is 2 g/kg ideal body weight per day?
500
Published in JAMA in 2025, this multicenter RCT specifically enrolled 627 critically ill patients with severe metabolic acidemia (pH ≤7.20) AND moderate-to-severe AKI (KDIGO stage 2–3). The primary outcome of 90 days all-cause mortality was not significant. However, KRT use was significantly lower in the bicarbonate group (HR for KRT initiation 0.59, 95% CI 0.46–0.75), and ICU-acquired bloodstream infections were 50% lower (4% vs. 9%).
What is BICAR-ICU 2 Trial
500
This oral small-molecule drug is a selective C5a receptor (C5aR1/CD88) antagonist that blocks the interaction between the potent anaphylatoxin C5a and its receptor on neutrophils. By preventing C5a-mediated neutrophil chemoattraction, activation, and pro-inflammatory cytokine release, it targets the alternative complement pathway central to the pathogenesis of ANCA-associated vasculitis — and notably does so without disrupting formation of the terminal complement complex (C5b-9), thereby preserving defense against encapsulated organisms like Neisseria meningitidis.
What is Avacopan?
500
These fan-shaped or "sheaves of wheat" crystals seen on urine microscopy under polarized light are highly birefringent and precipitate in acidic urine (pH < 5.5). Their formation can be prevented by aggressive hydration and urine alkalinization.
What are sulfadiazine crystals?